Parimi, S. et al. 2017. A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion. Canadian Urological Association Journal. 11, 10 (Oct. 2017), 350–5. DOI:https://doi.org/10.5489/cuaj.4415.